Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Novel peptides have been developed that are useful to induce Autoimmune Anterior Uveitis (AAU) and to treat symptoms associated with Anterior Uveitis. Additional potential uses for these peptides include identification of specific antigenic or uveitogeni More
Related Reports
Market Research Reports provided by reports.iptechex.com
May 2011 - 15 pages - $250
May 2008 - 70 pages - $1,999
Apr 2011 - 951 pages - $4,995
Oct 2010 - 25 pages - $250
May 2011 - 25 pages - $125
Nov 2010 - 28 pages - $600
Oct 2009 - 30 pages - $995
May 2011 - 25 pages - $125
Apr 2010 - 510 pages - $2,695
Wrigley's 5 Gum Case Study: remaining competitive in the gum market through a multi-sensory offering
Aug 2009 - 10 pages - $295
Your selection
Browse By
- Therapeutic target
- Auditory
- Opthalmic
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us